Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

ISH 2016

18 - 21 Apr 2016
Scottish Exhibition and Conference Centre (SECC), Glasgow, United Kingdom of Great Britain and Northern Ireland

Hodgkins - update on treatment strategies in children and adolescents

Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany
Hodgkins - update on treatment strategies in children and adolescents ( Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany )
6 May 2016

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA
Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )
6 May 2016

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi
Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )
6 May 2016

Radiotherapy in Hogkin lymphoma: reducing risk in later life

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Radiotherapy in Hogkin lymphoma: reducing risk in later life ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016

Comment on RESONATE2 and CLL115 trials

Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK
Comment on RESONATE2 and CLL115 trials ( Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK )
29 Apr 2016

Clinical cases employing novel agents in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA
Clinical cases employing novel agents in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA )
29 Apr 2016

Current trials in chronic lymphocytic leukaemia

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Current trials in chronic lymphocytic leukaemia ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
29 Apr 2016

Microenvironment of chronic lymphocytic leukaemia

Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Microenvironment of chronic lymphocytic leukaemia ( Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
29 Apr 2016

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia
Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )
29 Apr 2016

Ibrutinib as a frontline therapy in RESONATE2 trials for CLL

Prof Jan Burger, MD Anderson Cancer Center, Texas, USA
Ibrutinib as a frontline therapy in RESONATE2 trials for CLL ( Prof Jan Burger, MD Anderson Cancer Center, Texas, USA )
29 Apr 2016

The role of the microenvironment and novel therapies in CLL

Prof Jan Burger - MD Anderson Cancer Center, Texas, USA
The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )
29 Apr 2016

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016

AML during pregancy

Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK
AML during pregancy ( Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK )
27 Apr 2016

Germ line predisposition to leukaemia

Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA
Germ line predisposition to leukaemia ( Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA )
27 Apr 2016

The future of haematopathology

Prof Alberto Zamo - University of Verona, Verona, Italy
The future of haematopathology ( Prof Alberto Zamo - University of Verona, Verona, Italy )
27 Apr 2016

Frontline therapy in young patients with myeloma

Prof Philippe Moreau - University of Nantes, Nantes, France
Frontline therapy in young patients with myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
27 Apr 2016

Genomics of childhood ALL

Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel
Genomics of childhood ALL ( Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel )
27 Apr 2016

BSH 2016: Expert discussion on idelalisib

Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on idelalisib ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016

BSH 2016: Expert discussion on front line care in CLL

Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on front line care in CLL ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016